Literature DB >> 15754075

Economic evidence in multiple sclerosis: a review.

Gisela Kobelt1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15754075     DOI： 10.1007/s10198-005-0289-y

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN： 1618-7598


× No keyword cloud information.
  10 in total

1.  Multiple sclerosis and rehabilitation: an overview of the different rehabilitation settings.

Authors:  Andrea Tacchino; Giampaolo Brichetto; Paola Zaratin; Mario Alberto Battaglia; Michela Ponzio
Journal:  Neurol Sci       Date:  2017-09-15       Impact factor: 3.307

Review 2.  Socio-economic aspects of neuroimmunological diseases.

Authors:  Peter Rieckmann
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

3.  Change in perceived health insurance coverage among people with multiple sclerosis.

Authors:  Alyssa Pozniak; Louise Hadden; William Rhodes; Sarah Minden
Journal:  Int J MS Care       Date:  2014

4.  The direct cost of patients with multiple sclerosis: a survey from Italian MS centres.

Authors:  Berto P; Amato M P; Bellantonio P; Bortolon F; Cavalla P; Florio C; Lugaresi A; Montanari E; Rottoli M; Simone I L; Zaffaroni M
Journal:  Neurol Sci       Date:  2011-04-20       Impact factor: 3.307

5.  Cost of disorders of the brain in Italy.

Authors:  Maura Pugliatti; Patrik Sobocki; Ettore Beghi; Stefano Pini; Giovanni B Cassano; A Carlo Altamura; Sara Pozzoli; Giulio Rosati
Journal:  Neurol Sci       Date:  2008-05-16       Impact factor: 3.307

6.  [Cost of disorders of the brain in Austria in the year 2004].

Authors:  Johannes Wancata; Patrick Sobocki; Heinz Katschnig
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

7.  Economic Burden of Multiple Sclerosis in Low- and Middle-Income Countries: A Systematic Review.

Authors:  Jalal Dahham; Rana Rizk; Ingrid Kremer; Silvia M A A Evers; Mickaël Hiligsmann
Journal:  Pharmacoeconomics       Date:  2021-05-06       Impact factor: 4.981

8.  IS THE LINK BETWEEN HEALTH AND WEALTH CONSIDERED IN DECISION MAKING? RESULTS FROM A QUALITATIVE STUDY.

Authors:  Martina Garau; Koonal Kirit Shah; Priya Sharma; Adrian Towse
Journal:  Int J Technol Assess Health Care       Date:  2016-02-12       Impact factor: 2.188

Review 9.  Cost of Illness of Multiple Sclerosis - A Systematic Review.

Authors:  Olivia Ernstsson; Hanna Gyllensten; Kristina Alexanderson; Petter Tinghög; Emilie Friberg; Anders Norlund
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

10.  Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis.

Authors:  Matthijs Versteegh
Journal:  Pharmacoeconomics       Date:  2016-11       Impact factor: 4.981
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.